Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and navigate other challenges
Novo Nordisk is betting on a CEO shake-up to regain its weight loss drug edge over Eli Lilly
Posted in Uncategorized.